Alcoholism and mental illness: overlapping diseases requiring a renewed focus

References

• Agosti, V., & Levin, F. R. (2006). The effects of alcohol and drug dependence on the course of depression. The American Journal on Addictions, 15(1), 71–75. doi:10.1080/10550490500419102
   PubMed Web of Science ®Google Scholar
• Anthenelli, R. M. (2010). Focus on: Comorbid mental health disorders. Alcohol Research & Health, 33(1), 109–117.
   Web of Science ®Google Scholar
• Anton, R. F., Moak, D. H., Waid, L. R., Latham, P. K., Malcolm, R. J., & Dias, J. K. (1999). Naltrexone and cognitive behavioral therapy for the treatment of outpatient alcoholics: Results of a placebo-controlled trial. The American Journal of Psychiatry, 156(11), 1758–1764.
   PubMed Web of Science ®Google Scholar
• Assessment and Treatment of Patients with Coexisting Mental Illness and Alcohol and Other Drug Abuse. (1994). Rockville, MD: Substance Abuse and Mental Health Services Administration.
   Google Scholar
• Baker, A., Bucci, S., Lewin, T. J., Kay-Lambkin, F., Constable, P. M., & Carr, V. J. (2006). Cognitive-behavioural therapy for substance use disorders in people with psychotic disorders: Randomised controlled trial. The British Journal of Psychiatry, 188, 439–448. doi:10.1192/bjp.188.5.439
   PubMed Web of Science ®Google Scholar
• Barr, C. S., Dvoskin, R. L., Gupte, M., Sommer, W., Sun, H., Schwandt, M. L., … Heilig, M. (2009). Functional CRH variation increases stress-induced alcohol consumption in primates. Proceedings of the National Academy of Sciences of the United States of America, 106(34), 14593–14598. doi:10.1073/pnas.0902863106
   PubMed Web of Science ®Google Scholar
• Barrowclough, C., Haddock, G., Tarrier, N., Lewis, S. W., Moring, J., O'Brien, R., … McGovern, J. (2001). Randomized controlled trial of motivational interviewing, cognitive behavior therapy, and family intervention for patients with comorbid schizophrenia and substance use disorders. The American Journal of Psychiatry, 158(10), 1706–1713.
   PubMed Web of Science ®Google Scholar
• Barua, C. C., Begum, S. A., Barua, A. G., Borah, R. S., & Lahkar, M. (2013). Anxiolytic and anticonvulsant activity of methanol extract of leaves of Alternanthera brasiliana (L.) Kuntze (Amaranthaceae) in laboratory animals. Indian Journal of Experimental Biology, 51(6), 450–457.
   PubMed Web of Science ®Google Scholar
• Becker, H. C., Lopez, M. F., & Doremus-Fitzwater, T. L. (2011). Effects of stress on alcohol drinking: A review of animal studies. Psychopharmacology (Berl), 218(1), 131–156. doi:10.1007/s00213-011-2443-9
   PubMed Web of Science ®Google Scholar
• Boden, M. T., & Moos, R. (2009). Dually diagnosed patients’ responses to substance use disorder treatment. Journal of Substance Abuse Treatment, 37(4), 335–345. doi:10.1016/j.jsat.2009.03.012
   PubMed Web of Science ®Google Scholar
• Book, S. W., Thomas, S. E., Dempsey, J. P., Randall, P. K., & Randall, C. L. (2009). Social anxiety impacts willingness to participate in addiction treatment. Addictive Behaviors, 34(5), 474–476. doi:10.1016/j.addbeh.2008.12.011
   PubMed Web of Science ®Google Scholar
• Boschloo, L., Vogelzangs, N., Smit, J. H., van den Brink, W., Veltman, D. J., Beekman, A. T., & Penninx, B. W. (2011). Comorbidity and risk indicators for alcohol use disorders among persons with anxiety and/or depressive disorders: Findings from the Netherlands Study of Depression and Anxiety (NESDA). Journal of Affective Disorders, 131(1–3), 233–242. doi:10.1016/j.jad.2010.12.014
   PubMed Web of Science ®Google Scholar
• Boschloo, L., Vogelzangs, N., van den Brink, W., Smit, J. H., Beekman, A. T., & Penninx, B. W. (2012). Predictors of the 2-year recurrence and persistence of alcohol dependence. Addiction, 107(9), 1639–1640. doi:10.1111/j.1360-0443.2012.03860.x
   PubMed Web of Science ®Google Scholar
• Brewer, C. (1984). How effective is the standard dose of disulfiram? A review of the alcohol-disulfiram reaction in practice. The British Journal of Psychiatry, 144, 200–202.
   PubMed Web of Science ®Google Scholar
• Brunette, M. F., Drake, R. E., Woods, M., & Hartnett, T. (2001). A comparison of long-term and short-term residential treatment programs for dual diagnosis patients. Psychiatric Services, 52(4), 526–528.
   PubMed Web of Science ®Google Scholar
• Burnam, M. A., Morton, S. C., McGlynn, E. A., Petersen, L. P., Stecher, B. M., Hayes, C., & Vaccaro, J. V. (1995). An experimental evaluation of residential and nonresidential treatment for dually diagnosed homeless adults. Journal of Addictive Diseases, 14(4), 111–134.
   PubMed Web of Science ®Google Scholar
• Calsyn, R. J., Yonker, R. D., Lemming, M. R., Morse, G. A., & Klinkenberg, W. D. (2005). Impact of assertive community treatment and client characteristics on criminal justice outcomes in dual disorder homeless individuals. Criminal Behaviour and Mental Health, 15(4), 236–248. doi:10.1002/cbm.24
   PubMedGoogle Scholar
• Chick, J., Howlett, H., Morgan, M. Y., & Ritson, B. (2000). United Kingdom Multicentre Acamprosate Study (UKMAS): A 6-month prospective study of acamprosate versus placebo in preventing relapse after withdrawal from alcohol. Alcohol and Alcoholism, 35(2), 176–187.
   PubMed Web of Science ®Google Scholar
• Collins, G. B., McAllister, M. S., & Adury, K. (2006). Drug adjuncts for treating alcohol dependence. Cleveland Clinic Journal of Medicine, 73(7), 641–644, 647–648, 650–641, passim.
   PubMed Web of Science ®Google Scholar
• Data Spotlight. (2013). The NSDUH Report. Retrieved from http://samhsa.gov/data/spotlight/spot111-adults-mental-illness-substance-use-disorder.pdf
   Google Scholar
• De Leon, G., Sacks, S., Staines, G., & McKendrick, K. (2000). Modified therapeutic community for homeless mentally ill chemical abusers: Treatment outcomes. The American Journal of Drug and Alcohol Abuse, 26(3), 461–480.
   PubMed Web of Science ®Google Scholar
• DeVido, J. J., & Weiss, R. D. (2012). Treatment of the depressed alcoholic patient. Current Psychiatry Reports, 14(6), 610–618. doi:10.1007/s11920-012-0314-7
   PubMed Web of Science ®Google Scholar
• Drake, R. E., McHugo, G. J., Clark, R. E., Teague, G. B., Xie, H., Miles, K., & Ackerson, T. H. (1998). Assertive community treatment for patients with co-occurring severe mental illness and substance use disorder: A clinical trial. The American Journal of Orthopsychiatry, 68(2), 201–215.
   PubMed Web of Science ®Google Scholar
• Drake, R. E., O'Neal, E. L., & Wallach, M. A. (2008). A systematic review of psychosocial research on psychosocial interventions for people with co-occurring severe mental and substance use disorders. Journal of Substance Abuse Treatment, 34(1), 123–138. doi:10.1016/j.jsat.2007.01.011
   PubMed Web of Science ®Google Scholar
• Drake, R. E., Yovetich, N. A., Bebout, R. R., Harris, M., & McHugo, G. J. (1997). Integrated treatment for dually diagnosed homeless adults. The Journal of Nervous and Mental Disease, 185(5), 298–305.
   PubMed Web of Science ®Google Scholar
• Drobes, D. J., Anton, R. F., Thomas, S. E., & Voronin, K. (2004). Effects of naltrexone and nalmefene on subjective response to alcohol among non-treatment-seeking alcoholics and social drinkers. Alcoholism, Clinical and Experimental Research, 28(9), 1362–1370.
   PubMed Web of Science ®Google Scholar
• Edwards, S., Baynes, B. B., Carmichael, C. Y., Zamora-Martinez, E. R., Barrus, M., Koob, G. F., & Gilpin, N. W. (2013). Traumatic stress reactivity promotes excessive alcohol drinking and alters the balance of prefrontal cortex-amygdala activity. Translational Psychiatry, 3, e296. doi:10.1038/tp.2013.70
   PubMed Web of Science ®Google Scholar
• Edwards, S., & Koob, G. F. (2012). Experimental psychiatric illness and drug abuse models: From human to animal, an overview. Methods in Molecular Biology, 829, 31–48. doi:10.1007/978-1-61779-458-2_2
   PubMedGoogle Scholar
• Essock, S. M., Mueser, K. T., Drake, R. E., Covell, N. H., McHugo, G. J., Frisman, L. K., … Swain, K. (2006). Comparison of ACT and standard case management for delivering integrated treatment for co-occurring disorders. Psychiatric Services, 57(2), 185–196. doi:10.1176/appi.ps.57.2.185
   PubMed Web of Science ®Google Scholar
• Foa, E. B., Yusko, D. A., McLean, C. P., Suvak, M. K., Bux, D. A.Jr., Oslin, D., … Volpicelli, J. (2013). Concurrent naltrexone and prolonged exposure therapy for patients with comorbid alcohol dependence and PTSD: A randomized clinical trial. JAMA, 310(5), 488–495. doi:10.1001/jama.2013.8268
   PubMed Web of Science ®Google Scholar
• Franck, J., & Jayaram-Lindstrom, N. (2013). Pharmacotherapy for alcohol dependence: status of current treatments. Current Opinion in Neurobiology, 23(4), 692–699. doi:10.1016/j.conb.2013.05.005
   PubMed Web of Science ®Google Scholar
• Girard, T. A., Xing, H. C., Ward, G. R., & Wainwright, P. E. (2000). Early postnatal ethanol exposure has long-term effects on the performance of male rats in a delayed matching-to-place task in the Morris water maze. Alcoholism, Clinical and Experimental Research, 24(3), 300–306.
   PubMed Web of Science ®Google Scholar
• Graeber, D. A., Moyers, T. B., Griffith, G., Guajardo, E., & Tonigan, S. (2003). A pilot study comparing motivational interviewing and an educational intervention in patients with schizophrenia and alcohol use disorders. Community Mental Health Journal, 39(3), 189–202.
   PubMed Web of Science ®Google Scholar
• Greenfield, S. F., Weiss, R. D., Muenz, L. R., Vagge, L. M., Kelly, J. F., Bello, L. R., & Michael, J. (1998). The effect of depression on return to drinking: A prospective study. Archives of General Psychiatry, 55(3), 259–265.
   PubMed Web of Science ®Google Scholar
• Hartmann, P., Chen, P., Wang, H. J., Wang, L., McCole, D. F., Brandl, K., … Schnabl, B. (2013). Deficiency of intestinal mucin-2 ameliorates experimental alcoholic liver disease in mice. Hepatology, 58(1), 108–119. doi:10.1002/hep.26321
   PubMed Web of Science ®Google Scholar
• Haver, B., & Gjestad, R. (2005). Phobic anxiety and depression as predictor variables for treatment outcome. A LISREL analysis on treated female alcoholics. Nordic Journal of Psychiatry, 59(1), 25–30. doi:10.1080/08039480510018797
   PubMed Web of Science ®Google Scholar
• Ho, A. P., Tsuang, J. W., Liberman, R. P., Wang, R., Wilkins, J. N., Eckman, T. A., & Shaner, A. L. (1999). Achieving effective treatment of patients with chronic psychotic illness and comorbid substance dependence. The American Journal of Psychiatry, 156(11), 1765–1770.
   PubMed Web of Science ®Google Scholar
• Hobbs, J. D., Kushner, M. G., Lee, S. S., Reardon, S. M., & Maurer, E. W. (2011). Meta-analysis of supplemental treatment for depressive and anxiety disorders in patients being treated for alcohol dependence. The American Journal on Addictions, 20(4), 319–329. doi:10.1111/j.1521-0391.2011.00140.x
   PubMed Web of Science ®Google Scholar
• Hunter, S. B., Watkins, K. E., Hepner, K. A., Paddock, S. M., Ewing, B. A., Osilla, K. C., & Perry, S. (2012). Treating depression and substance use: A randomized controlled trial. Journal of Substance Abuse Treatment, 43(2), 137–151. doi:10.1016/j.jsat.2011.12.004
   PubMed Web of Science ®Google Scholar
• Jerrell, J. M., & Ridgely, M. S. (1995). Comparative effectiveness of three approaches to serving people with severe mental illness and substance abuse disorders. The Journal of Nervous and Mental Disease, 183(9), 566–576.
   PubMed Web of Science ®Google Scholar
• Jerrell, J. M., & Ridgely, M. S. (1999). Impact of robustness of program implementation on outcomes of clients in dual diagnosis programs. Psychiatric Services, 50(1), 109–112.
   PubMed Web of Science ®Google Scholar
• Kavanagh, D. J., Young, R., White, A., Saunders, J. B., Wallis, J., Shockley, N., … Clair, A. (2004). A brief motivational intervention for substance misuse in recent-onset psychosis. Drug and Alcohol Review, 23(2), 151–155. doi:10.1080/09595230410001704127
   PubMed Web of Science ®Google Scholar
• Kay-Lambkin, F. J., Baker, A. L., Kelly, B., & Lewin, T. J. (2011). Clinician-assisted computerised versus therapist-delivered treatment for depressive and addictive disorders: A randomised controlled trial. The Medical Journal of Australia, 195(3), S44–50.
   PubMed Web of Science ®Google Scholar
• Kessler, R. C., Chiu, W. T., Demler, O., Merikangas, K. R., & Walters, E. E. (2005). Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry, 62(6), 617–627. doi:10.1001/archpsyc.62.6.617
   PubMed Web of Science ®Google Scholar
• Kushner, M. G., Abrams, K., Thuras, P., Hanson, K. L., Brekke, M., & Sletten, S. (2005). Follow-up study of anxiety disorder and alcohol dependence in comorbid alcoholism treatment patients. Alcoholism, Clinical and Experimental Research, 29(8), 1432–1443.
   PubMed Web of Science ®Google Scholar
• Lehman, A. F., Herron, J. D., Schwartz, R. P., & Myers, C. P. (1993). Rehabilitation for adults with severe mental illness and substance use disorders. A clinical trial. The Journal of Nervous and Mental Disease, 181(2), 86–90.
   PubMed Web of Science ®Google Scholar
• Litt, M. D., Kadden, R. M., & Kabela-Cormier, E. (2009). Individualized assessment and treatment program for alcohol dependence: Results of an initial study to train coping skills. Addiction, 104(11), 1837–1838. doi:10.1111/j.1360-0443.2009.02693.x
   PubMed Web of Science ®Google Scholar
• Magura, S., Rosenblum, A., Villano, C. L., Vogel, H. S., Fong, C., & Betzler, T. (2008). Dual-focus mutual aid for co-occurring disorders: A quasi-experimental outcome evaluation study. The American Journal of Drug and Alcohol Abuse, 34(1), 61–74. doi:10.1080/00952990701764623
   PubMed Web of Science ®Google Scholar
• Mangrum, L. F., Spence, R. T., & Lopez, M. (2006). Integrated versus parallel treatment of co-occurring psychiatric and substance use disorders. Journal of Substance Abuse Treatment, 30(1), 79–84. doi:10.1016/j.jsat.2005.10.004
   PubMed Web of Science ®Google Scholar
• Mann, K. (2004). Pharmacotherapy of alcohol dependence: A review of the clinical data. CNS Drugs, 18(8), 485–504.
   PubMed Web of Science ®Google Scholar
• Maynard, M. E., & Leasure, J. L. (2013). Exercise enhances hippocampal recovery following Binge Ethanol exposure. PLoS One, 8(9), e76644. doi:10.1371/journal.pone.0076644
   Google Scholar
• McHugo, G. J., Drake, R. E., Teague, G. B., & Xie, H. (1999). Fidelity to assertive community treatment and client outcomes in the New Hampshire dual disorders study. Psychiatric Services, 50(6), 818–824.
   PubMed Web of Science ®Google Scholar
• Meyer, E. M., Long, V., Fanselow, M. S., & Spigelman, I. (2013). Stress increases voluntary alcohol intake, but does not alter established drinking habits in a rat model of posttraumatic stress disorder. Alcoholism, Clinical and Experimental Research, 37(4), 566–574. doi:10.1111/acer.12012
   PubMed Web of Science ®Google Scholar
• Moggi, F., Ouimette, P. C., Moos, R. H., & Finney, J. W. (1999). Dual diagnosis patients in substance abuse treatment: Relationship of general coping and substance-specific coping to 1-year outcomes. Addiction, 94(12), 1805–1816.
   PubMed Web of Science ®Google Scholar
• Monti, P. M., Rohsenow, D. J., Swift, R. M., Gulliver, S. B., Colby, S. M., Mueller, T. I., … Asher, M. K. (2001). Naltrexone and cue exposure with coping and communication skills training for alcoholics: treatment process and 1-year outcomes. Alcoholism, Clinical and Experimental Research, 25(11), 1634–1647.
   PubMed Web of Science ®Google Scholar
• Morris, P. L., Hopwood, M., Whelan, G., Gardiner, J., & Drummond, E. (2001). Naltrexone for alcohol dependence: a randomized controlled trial. Addiction, 96(11), 1565–1573. doi:10.1080/09652140120080705
   PubMed Web of Science ®Google Scholar
• Morse, G. A., Calsyn, R. J., Dean Klinkenberg, W., Helminiak, T. W., Wolff, N., Drake, R. E., … McCudden, S. (2006). Treating homeless clients with severe mental illness and substance use disorders: Costs and outcomes. Community Mental Health Journal, 42(4), 377–404. doi:10.1007/s10597-006-9050-y
   PubMed Web of Science ®Google Scholar
• Najavits, L. M., & Johnson, K. M. (2014). Pilot study of creating change, a new past-focused model for PTSD and substance abuse. The American Journal on Addictions. doi: 10.1111/j.1521-0391.2014.12127.x
   PubMedGoogle Scholar
• Najavits, L. M., Schmitz, M., Gotthardt, S., & Weiss, R. D. (2005). Seeking safety plus exposure therapy: An outcome study on dual diagnosis men. Journal of Psychoactive Drugs, 37(4), 425–435.
   PubMed Web of Science ®Google Scholar
• Najavits, L. M., Weiss, R. D., Shaw, S. R., & Muenz, L. R. (1998). “Seeking safety”: Outcome of a new cognitive-behavioral psychotherapy for women with posttraumatic stress disorder and substance dependence. Journal of Traumatic Stress, 11(3), 437–456. doi:10.1023/A:1024496427434
   PubMed Web of Science ®Google Scholar
• Nelson, T. J., & Alkon, D. L. (2007). Protection against beta-amyloid-induced apoptosis by peptides interacting with beta-amyloid. The Journal of Biological Chemistry, 282(43), 31238–31249. doi:10.1074/jbc.M705558200
   PubMed Web of Science ®Google Scholar
• Nuttbrock, L. A., Rahav, M., Rivera, J. J., Ng-Mak, D. S., & Link, B. G. (1998). Outcomes of homeless mentally ill chemical abusers in community residences and a therapeutic community. Psychiatric Services, 49(1), 68–76.
   PubMed Web of Science ®Google Scholar
• O'Malley, S. S., Jaffe, A. J., Chang, G., Rode, S., Schottenfeld, R., Meyer, R. E., & Rounsaville, B. (1996). Six-month follow-up of naltrexone and psychotherapy for alcohol dependence. Archives of General Psychiatry, 53(3), 217–224.
   PubMed Web of Science ®Google Scholar
• Peters, S., Slattery, D. A., Flor, P. J., Neumann, I. D., & Reber, S. O. (2013). Differential effects of baclofen and oxytocin on the increased ethanol consumption following chronic psychosocial stress in mice. Addiction Biology, 18(1), 66–77. doi:10.1111/adb.12001
   PubMed Web of Science ®Google Scholar
• Petrakis, I. L., Gonzalez, G., Rosenheck, R., & Krystal, J. H. (2002). Comorbidity of alcoholism and psychiatric disorders: An overview. Alcohol and Comorbid Mental Health Disorders, 26(2), 81–89.
   Web of Science ®Google Scholar
• Sacks, S., McKendrick, K., Sacks, J. Y., Banks, S., & Harle, M. (2008). Enhanced outpatient treatment for co-occurring disorders: Main outcomes. Journal of Substance Abuse Treatment, 34(1), 48–60. doi:10.1016/j.jsat.2007.01.009
   PubMed Web of Science ®Google Scholar
• Samet, S., Fenton, M. C., Nunes, E., Greenstein, E., Aharonovich, E., & Hasin, D. (2013). Effects of independent and substance-induced major depressive disorder on remission and relapse of alcohol, cocaine and heroin dependence. Addiction, 108(1), 115–123. doi:10.1111/j.1360-0443.2012.04010.x
   PubMed Web of Science ®Google Scholar
• Shivani, R., Goldsmith, R. J., & Anthenelli, R. M. (2002). Alcoholism and psychiatric disorders: Diagnostic challenges. Alcohol and Comorbid Mental Health Disorders, 26(2), 90–98.
   Web of Science ®Google Scholar
• Timko, C., & Sempel, J. M. (2004). Intensity of acute services, self-help attendance and one-year outcomes among dual diagnosis patients. Journal of Studies on Alcohol, 65(2), 274–282.
   PubMed Web of Science ®Google Scholar
• Tran, T. D., Cronise, K., Marino, M. D., Jenkins, W. J., & Kelly, S. J. (2000). Critical periods for the effects of alcohol exposure on brain weight, body weight, activity and investigation. Behavioural Brain Research, 116(1), 99–110.
   PubMed Web of Science ®Google Scholar
• Warnock, K. T., Yang, A. R., Yi, H. S., June, H. L.Jr., Kelly, T., Basile, A. S., … June, H. L. (2012). Amitifadine, a triple monoamine uptake inhibitor, reduces binge drinking and negative affect in an animal model of co-occurring alcoholism and depression symptomatology. Pharmacology, Biochemistry, and Behavior, 103(1), 111–118. doi:10.1016/j.pbb.2012.07.014
   PubMed Web of Science ®Google Scholar
• Whitworth, A. B., Fischer, F., Lesch, O. M., Nimmerrichter, A., Oberbauer, H., Platz, T., … Fleischhacker, W. W. (1996). Comparison of acamprosate and placebo in long-term treatment of alcohol dependence. The Lancet, 347(9013), 1438–1442.
   PubMed Web of Science ®Google Scholar
• WHO (2011). Alcohol. Retrieved 29 October, 2013, from http://www.who.int/mediacentre/factsheets/fs349/en/
   Google Scholar
• Yang, A. R., Yi, H. S., Warnock, K. T., Mamczarz, J., June, H. L.Jr., Mallick, N., … June, H. L.Sr. (2012). Effects of the triple monoamine uptake inhibitor DOV 102,677 on alcohol-motivated responding and antidepressant activity in alcohol-preferring (P) rats. Alcoholism, Clinical and Experimental Research, 36(5), 863–873. doi:10.1111/j.1530-0277.2011.01671.x
   PubMed Web of Science ®Google Scholar
• Zorzano, A., & Herrera, E. (1990). In vivo ethanol elimination in man, monkey and rat: a lack of relationship between the ethanol metabolism and the hepatic activities of alcohol and aldehyde dehydrogenases. Life Sciences, 46(3), 223–230.
   PubMed Web of Science ®Google Scholar